| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2005;36:2116.)
© 2005 American Heart Association, Inc.
Original Contributions |
From the Alzheimer Center (W.M.v.d.F., E.C.W.v.S., F.B., P.S.) and the Departments of Neurology (W.M.v.d.F., E.C.W.v.S., P.S.) and Radiology (F.B.), and the Image Analysis Centre (IAC) (E.C.W.v.S., F.B.), Vrije Universiteit Medical Center, Amsterdam, The Netherlands; the Serviço de Neurologia (A.V., S.M.), Centro de Estudos Egas Moniz, Hospital de Santa Maria, Lisboa, Portugal; the Department of Neurological and Psychiatric Sciences (L.P., D.I.), University of Florence, Florence, Italy; the Memory Research Unit, Department of Clinical Neurosciences (T.E.), Helsinki University, Helsinki, Finland; the Neurotec Department, Section of Clinical Geriatrics (M.C.), Karolinska Universitetssjukhuset, Huddinge University Hospital, Huddinge, Sweden; the Memory Disorders Research Unit, Department of Neurology (F.W.), Copenhagen University Hospital, Copenhagen, Denmark; and the Department of Neurology and MRI Institute (R.S., F.F.), Medical University, Graz, Austria.
Correspondence to W. M. van der Flier, PhD, Department of Neurology and Alzheimer Center, Vrije Universiteit Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands. E-mail wm.vdflier{at}vumc.nl
Background and Purpose On cerebral magnetic resonance imaging (MRI), white matter hyperintensities (WMH) and lacunes are generally viewed as evidence of small vessel disease. The clinical significance of small vessel disease in terms of global cognitive function has as yet not been completely clarified. We investigated the independent contribution of WMH and lacunes to general cognitive function in a group of independently living elderly with varying degrees of small vessel disease.
Methods Data were drawn from the multicenter, multinational Leukokraurosis and Disability (LADIS) study. There were 633 independently living participants. General cognitive function was assessed using the Mini Mental State Examination (MMSE) and the modified Alzheimer Disease Assessment Scale (ADAS). On MRI, WMH was rated as mild, moderate, or severe. Lacunes were rated as none, few (1 to 3), or many (4 or more).
Results In the basic analysis, increasing severity of both WMH and lacunes was related to deteriorating score on the MMSE and ADAS. When WMH and lacunes were entered simultaneously, both MRI measures remained significantly associated with MMSE score. Increasing severity of WMH remained associated with ADAS score, whereas the association with lacunes became less prominent. These associations were independent of other risk factors for dementia, like education, depression, vascular risk factors, or stroke.
Conclusion We found WMH and lacunes to be independently associated with general cognitive function in a sample of independently living elderly. These results highlight the fact that WMH and lacunes should both be evaluated when assessing small vessel disease in relation to cognitive function.
Key Words: cognition elderly lacunes small vessel disease white matter hyperintensities
Related Articles:
Stroke 2005 36: 2062-2063.
Stroke 2005 0: 01.STR.0000179040.36574.99v1.
This article has been cited by other articles:
![]() |
S. Bombois, S. Debette, A. Bruandet, X. Delbeuck, C. Delmaire, D. Leys, and F. Pasquier Vascular Subcortical Hyperintensities Predict Conversion to Vascular and Mixed Dementia in MCI Patients Stroke, July 1, 2008; 39(7): 2046 - 2051. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Ikram, M. van Oijen, F. J. de Jong, J. A. Kors, P. J. Koudstaal, A. Hofman, J. C.M. Witteman, and M. M.B. Breteler Unrecognized Myocardial Infarction in Relation to Risk of Dementia and Cerebral Small Vessel Disease Stroke, May 1, 2008; 39(5): 1421 - 1426. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pantoni Leukoaraiosis: From an Ancient Term to an Actual Marker of Poor Prognosis Stroke, May 1, 2008; 39(5): 1401 - 1403. [Full Text] [PDF] |
||||
![]() |
G. F. OXENKRUG Genetic and Hormonal Regulation of Tryptophan Kynurenine Metabolism: Implications for Vascular Cognitive Impairment, Major Depressive Disorder, and Aging Ann. N.Y. Acad. Sci., December 1, 2007; 1122(1): 35 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Verdelho, S. Madureira, J. M Ferro, A.-M. Basile, H. Chabriat, T. Erkinjuntti, F. Fazekas, M. Hennerici, J. O'Brien, L. Pantoni, et al. Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study J. Neurol. Neurosurg. Psychiatry, December 1, 2007; 78(12): 1325 - 1330. [Abstract] [Full Text] [PDF] |
||||
![]() |
L BRONGE and L-O WAHLUND White matter changes in dementia: does radiology matter? Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S115 - S120. [Abstract] [Full Text] [PDF] |
||||
![]() |
S MILLS, J CAIN, N PURANDARE, and A JACKSON Biomarkers of cerebrovascular disease in dementia Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S128 - S145. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gold, P. Giannakopoulos, F. R Herrmann, C. Bouras, and E. Kovari Identification of Alzheimer and vascular lesion thresholds for mixed dementia Brain, November 1, 2007; 130(11): 2830 - 2836. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Bowler Modern concept of vascular cognitive impairment Br. Med. Bull., September 1, 2007; 83(1): 291 - 305. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schmidt, K. Petrovic, S. Ropele, C. Enzinger, and F. Fazekas Progression of Leukoaraiosis and Cognition Stroke, September 1, 2007; 38(9): 2619 - 2625. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Kalaria Rounding up the usual suspects: Lacunar infarction and impairment in CADASIL Neurology, July 10, 2007; 69(2): 131 - 132. [Full Text] [PDF] |
||||
![]() |
L. A. van de Pol, E. S. C. Korf, W. M. van der Flier, H. R. Brashear, N. C. Fox, F. Barkhof, and P. Scheltens Magnetic Resonance Imaging Predictors of Cognition in Mild Cognitive Impairment Arch Neurol, July 1, 2007; 64(7): 1023 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jokinen, C. Ryberg, H. Kalska, R. Ylikoski, E. Rostrup, M. B Stegmann, G. Waldemar, S. Madureira, J. M Ferro, E. C W van Straaten, et al. Corpus callosum atrophy is associated with mental slowing and executive deficits in subjects with age-related white matter hyperintensities: the LADIS Study J. Neurol. Neurosurg. Psychiatry, May 1, 2007; 78(5): 491 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Freeman, C. J. Collura-Burke, N. J. Patronas, L. S. Ilcus, D. Darnell, J. Davis, J. M. Puck, and S. M. Holland Brain Abnormalities in Patients With Hyperimmunoglobulin E Syndrome Pediatrics, May 1, 2007; 119(5): e1121 - e1125. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lin, L. Svensson, R. Gupta, B. Lytle, and D. Krieger Chronic ischemic cerebral white matter disease is a risk factor for nonfocal neurologic injury after total aortic arch replacement J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 1059 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M VAN DER FLIER, F. BARKHOF, and P. SCHELTENS Shifting Paradigms in Dementia: Toward Stratification of Diagnosis and Treatment Using MRI Ann. N.Y. Acad. Sci., February 1, 2007; 1097(1): 215 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Drachman Aging of the brain, entropy, and Alzheimer disease Neurology, October 24, 2006; 67(8): 1340 - 1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Munoz Leukoaraiosis and Ischemia: Beyond the Myth Stroke, June 1, 2006; 37(6): 1348 - 1349. [Full Text] [PDF] |
||||
![]() |
W.T. Longstreth Jr Brain Vascular Disease Overt and Covert Stroke, October 1, 2005; 36(10): 2062 - 2063. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |